Trending...
- Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep
- Boston: Mayor Walsh announces 2021 day of celebration in honor of Rev. Dr. Martin Luther King Jr.
- Boston: January 2021: Latest updates from the Department of Neighborhood Development
WALTHAM, Mass. and SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Innoforce, a bioinnovation-enabling company, today announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing. The new facility is expected to be completed in 2022.
The new state-of-the-art Good Manufacturing Practices (GMP) facility will become part of Thermo Fisher's extensive global pharma services network, which includes leading capabilities for drug product development, biologics manufacturing, sterile fill-finish, clinical trials packaging and logistics. The Hangzhou site will also incorporate stringent quality control processes that meet or exceed regulatory guidelines established by the China National Medical Products Administration (NMPA), the U.S. FDA and appropriate EMEA authorities.
"Our agreement with Innoforce will provide critical support in helping to meet the high demand for biologics in China," said Michel Lagarde, executive vice president, Thermo Fisher Scientific. "The addition of the Hangzhou site will expand our existing global network and provide drug development and manufacturing services for customers in China, as well as for global customers seeking capabilities in the region."
Innoforce CEO Yuling Li said, "To successfully bring novel therapies to market domestically and internationally, emerging biotech companies increasingly need partners with expertise in development and manufacturing and deep global regulatory knowledge. Through our partnership with Thermo Fisher, we can offer an accelerated pathway for biopharmaceutical manufacturers in China – and outside as well – to bring innovative therapies to the world."
More on Boston Chron
Until the site is operational, new and existing customers can access Thermo Fisher's global biologics and steriles network, which includes sites across the U.S., Europe and Asia-Pacific, and then seamlessly transition to the new Hangzhou site after completion.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.
About Innoforce Pharmaceuticals
Innoforce is a bioinnovation-enabling corporation located in the heart of Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders are global biopharmaceutical industry executives including Innoforce Chairman Dr. Guo-Liang Yu and CEO Dr. Yuling Li and the core management team has extensive international experience and expertise in technology innovation, product development and business operations. The first phase of the Innoforce campus covers 21 acres including biologic process development laboratories, scale-up and R&D labs, and manufacturing facilities for protein, cell and gene therapies. For more information, please visit www.innoforcepharma.com.
More on Boston Chron
Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: [email protected]
Website: www.thermofisher.com
Ken Carter
Phone: 240-421-3838
E-mail: [email protected]
Website: www.innoforcepharma.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: [email protected]
Bing Zhu
Phone: +86 186 2136 8339
E-mail: [email protected]
SOURCE Thermo Fisher Scientific
Related Links
http://www.thermofisher.com
The new state-of-the-art Good Manufacturing Practices (GMP) facility will become part of Thermo Fisher's extensive global pharma services network, which includes leading capabilities for drug product development, biologics manufacturing, sterile fill-finish, clinical trials packaging and logistics. The Hangzhou site will also incorporate stringent quality control processes that meet or exceed regulatory guidelines established by the China National Medical Products Administration (NMPA), the U.S. FDA and appropriate EMEA authorities.
"Our agreement with Innoforce will provide critical support in helping to meet the high demand for biologics in China," said Michel Lagarde, executive vice president, Thermo Fisher Scientific. "The addition of the Hangzhou site will expand our existing global network and provide drug development and manufacturing services for customers in China, as well as for global customers seeking capabilities in the region."
Innoforce CEO Yuling Li said, "To successfully bring novel therapies to market domestically and internationally, emerging biotech companies increasingly need partners with expertise in development and manufacturing and deep global regulatory knowledge. Through our partnership with Thermo Fisher, we can offer an accelerated pathway for biopharmaceutical manufacturers in China – and outside as well – to bring innovative therapies to the world."
More on Boston Chron
- Introducing BIAMI.IO Apps Framework
- Pro Golfer Kamaiu Johnson Joins Cambridge Mobile Telematics as Brand Ambassador
- Empirix Helps CEHE Confidently Migrate to Five9 Cloud-Based Contact Center Software USA - English USA - English
- Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area
- Manulife Investment Management announces new managing director of institutional distribution, southeast region
Until the site is operational, new and existing customers can access Thermo Fisher's global biologics and steriles network, which includes sites across the U.S., Europe and Asia-Pacific, and then seamlessly transition to the new Hangzhou site after completion.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.
About Innoforce Pharmaceuticals
Innoforce is a bioinnovation-enabling corporation located in the heart of Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders are global biopharmaceutical industry executives including Innoforce Chairman Dr. Guo-Liang Yu and CEO Dr. Yuling Li and the core management team has extensive international experience and expertise in technology innovation, product development and business operations. The first phase of the Innoforce campus covers 21 acres including biologic process development laboratories, scale-up and R&D labs, and manufacturing facilities for protein, cell and gene therapies. For more information, please visit www.innoforcepharma.com.
More on Boston Chron
- Boston: Meet some of this year's Opportunity Fund grantees
- City Streaming TV, a Streaming Television Inc Network Launches, bringing Community and Faith Leaders into local TV's, At No Cost
- Perini Management Services, Inc. Announces Two Federal Contracts Collectively Valued at $66.9 Million
- "GLORY of HISTORY" Hip-Hop Music Video Looks At Voter's Choice
- BoatDealers.ca Surges with Record Traffic in 2020
Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: [email protected]
Website: www.thermofisher.com
Ken Carter
Phone: 240-421-3838
E-mail: [email protected]
Website: www.innoforcepharma.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1294
E-mail: [email protected]
Bing Zhu
Phone: +86 186 2136 8339
E-mail: [email protected]
SOURCE Thermo Fisher Scientific
Related Links
http://www.thermofisher.com
Filed Under: Business
0 Comments
Latest on Boston Chron
- Latino Leaders Network to Honor Tucson Mayor Regina Romero with the Antonio Villaraigosa Leadership Award at the 34th Tribute to Mayors
- 40 Years in Yiddishland: The Yiddish Book Center celebrates the Klezmer Conservatory Band
- Applications being accepted for Boston school committee
- The UK's Leading Digital Marketing Agency, Finsbury Media Announces Employees Will Be Allowed To Work From Home:
- Loomis Sayles Welcomes Marques Benton as Chief Diversity, Equity and Inclusion Officer
- NMEA 2000 Development and Prototyping Boards for Marine Applications
- ICTBroadast Version 4.1, Advance call center software for your needs
- Former US Deputy Assistant Secretary of Defense Dr. Joe Felter joins 6K's Advisory Board
- BrickBio Creates Novel Class of Bispecific Antibody Drug Conjugate and Receives Green Light on Next Phase of Therapeutic Deal with Large Pharma Partner
- Foundation Medicine Announces Executive Leadership Transition
- CEO of Industrial Giant ABB in Brazil Joins CEO Coaching International
- EdiGene Announces Approval of its IND Application for its CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy ET-01 in β-thalassemia by China National Medical Products Administration
- Fighting Pest Problems with The Safest Pest Control Dubai Residents Can Get
- Best Advertising Methods To Attract People To Your Events Post COVID-19 by Duluth Businessman Ismail Sirdah
- Passage of legislation to support creation of affordable housing, workforce training in Boston celebrated
- Boston: 2021 day of celebration to honor Rev. Dr. Martin Luther King Jr.
- City houses 1,700 children experiencing housing instability through Boston housing authority vouchers
- Thirteen MBK Senior Living Communities Receive "2021 Best of Senior Living" Distinction
- Grassroots Advocacy Group Urges Biden Administration to Appoint a Doctoral Level Mental Health Professional to Lead SAMHSA
- Boston: January 2021: Latest updates from the Department of Neighborhood Development